Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

L.A. McKeown

May 23, 2019

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

Presentation EuroPCR 2016

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

Presenter: Bernando Cortese

May 23, 2016

News Conference News EuroPCR 2016

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Jason Kahn

May 22, 2013

Advertisement

TCTMD’s Top 10 Most Popular Stories for May 2019

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content